FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileOraSure Technologies, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
OSUR
OraSure Technologies, Inc. Stock AnalysisComprehensive stock analysis for OraSure Technologies, Inc. (OSUR) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisOSUR
OSUR
OraSure Technologies, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
OSUR
  1. Home
  2. Stocks
  3. OraSure Technologies, Inc.

OraSure Technologies, Inc.

🇺🇸OSUR•NASDAQ

OraSure Technologies, Inc.

🇺🇸OSUR•NASDAQ
Market cap
$238.90M

Your view on OSUR

Mkt Cap
$238.90M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About OraSure Technologies, Inc.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Carrie Eglinton Manner
Headquarters
220 East First Street, Bethlehem, PA, US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Carrie Eglinton Manner
Headquarters
220 East First Street, Bethlehem, PA, US
Description

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions.

The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test.

It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND genomics laboratory services.

In addition, the company provides ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; offers Colli-Pee collection device for the volumetric collection of first void urine; and manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the academic research and commercial applications, including ancestry, disease risk management, lifestyle, and animal testing.

Further, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities.

OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for OraSure Technologies, Inc.. Starting points for OraSure Technologies, Inc.: EPS -$0.70, beta 1.06 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for OraSure Technologies, Inc.. Trailing twelve-month EPS for OraSure Technologies, Inc. stands at -$0.70. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for OraSure Technologies, Inc.. OraSure Technologies, Inc. has reported as a listed company since 1986. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold OSUR12 companies
More Medical - Instruments & Supplies companies
TickerTypeCompanySectorExchangeMkt cap
NNCSFNanosonics LimitedHealthcareOTC$697.7M
NNNNAnbio Biotechnology Class A Ordinary SharesHealthcareNASDAQ$145.7M
NPRRFNipro CorporationHealthcareOTC$1.3B
NVSTEnvista Holdings CorpHealthcareNYSE$3.7B
NXGLNEXGEL, Inc.HealthcareNASDAQ$1.7M
NXGLWNEXGEL, Inc.HealthcareNASDAQ$550,561
OJSYOJsys, Inc.HealthcareOTC$454,285
OSX.AXOsteopore LimitedHealthcareASX—
OTC.VOcumetics Technology Corp.HealthcareTSXV$32.9M
OTCFFOcumetics Technology Corp.HealthcareOTC$16.0M
PDEXPro-Dex, Inc.HealthcareNASDAQ$201.6M
PDMIParadigm Medical Industries, Inc.HealthcareOTC$324,879
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold OraSure Technologies, Inc., and how their positions are changing. At a $238.9M market value, institutional positions materially move OraSure Technologies, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by OraSure Technologies, Inc. executives and directors. Shares of OraSure Technologies, Inc. have traded between $2.10 and $4.22 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming OraSure Technologies, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for OraSure Technologies, Inc.. Coverage tracks OraSure Technologies, Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of OraSure Technologies, Inc.

OSUR AnalysisFair
Past
5
Growth
1
Health
5
Profit
1
Value
1